Diabetes Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Induced pluripotent stem (IPS) celssAs part of the effort to understand the development of genetic diseases, Boston Children’s has created induced pluripotent stem (iPS) cells, which are cells taken from patients and reprogrammed to look and function like embryonic stem cells. Scientists use these iPS cells to model the genetic diseases of the patients from whom they were taken, including Type I diabetes patients.

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944